Search
for
Sort by
Research 61–90 of 876
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Common Features of Periocular Tinea
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- An eruption of numerous spiny papules in a pediatric transplant patient
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows
- Prostaglandin analogs for hair growth: Great Expectations
- Frontal fibrosing alopecia
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- More Yellow Ovaries
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Alopecia Areata Ophiasic with Ciliary Madarosis in A Pediatric Patient: Case Report
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Contact dermatitis to Minoxidil
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- OVS Announces
- Treatment of Chemotherapy Induced Alopecia
- Topical and intralesional therapies for alopecia areata
- Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes
- Alopecia areata: Part 2: treatment.